Fennec Pharmaceuticals Inc. Financial Ratios — FENC Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	-113.52	-135.45	-46.47	-41.14	-76.99	-88.46	-77.36	- -	- -	- -	- -
Return on Assets (%)	82.6	-133.83	89.63	-105.53	-38.87	-111.76	-43.53	-38.51	-68.88	-79.49	-64.45	-96.1	-59.64	-1.21	-16.87
Return on Capital (%)	-185.77	- -	-57.55	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	100	- -	94.4	94.08	93.3	91.57
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-10,520.59	- -	-1,481.3	-61.44	6.9	-13.98
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-10,520.59	- -	-1,481.3	-61.44	5.21	-14.22
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-389.41	- -	- -	59.11	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-10,652.35	- -	-1,544.89	-75.5	-0.15	-21.58
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-10,652.35	- -	-1,544.89	-75.5	-0.92	-21.82
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-10,652.35	- -	-1,544.89	-75.5	-0.92	-21.82
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-113.52	-135.45	-46.47	-41.14	-76.99	-88.46	-77.36	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5	25	31	19	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5	25	31	19	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.29	-1.1	-2.37	5.9	- -
Net Debt/EBITDA	1.54	0.64	0.86	0.8	0.5	1.37	4.07	2.19	1.05	1.7	0.94	-0.05	-1.35	-2.23	5.89
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.29	-1.1	-2.37	7.8	- -
Net Debt/EBIT	1.54	0.64	0.86	0.8	0.5	1.37	4.07	2.19	1.05	1.7	0.94	-0.05	-1.35	-2.94	5.8
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,987.22	-136.69	-23.25	-3.85	0.81	-3
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,987.22	-136.69	-23.25	-3.85	0.81	-3
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,987.22	-136.69	-23.25	-3.85	0.61	-3.05
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	3	4	2
Common Equity/Total Assets	-2.24	-209.6	-83.05	25.84	53.78	89.88	94.21	92.87	83.95	92.53	70.37	-9.54	-43.26	-13.06	50.28
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	31.63	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	24.03	111.5	160.02	143.58	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.25	92.43	115.14	43.02	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	31.63	-969.21	-266.32	-329.36	- -
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	24.03	111.5	160.12	143.6	- -
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.25	92.43	115.22	43.03	- -
Net Debt to Equity	4,414.17	46.46	114.3	-376.35	-171.9	-109.97	-105.62	-106.89	-114.95	-104.38	-102.16	-43.79	-151.97	124.25	-103.71
Net Debt/Capital (%)	97.78	31.72	53.34	136.19	239.09	1,102.81	1,880.24	1,551.84	769.01	2,381.79	4,738.82	-77.91	291.4	55.42	2,795.44
EBITDA	-3	-4	-2	-3	-2	-3	-7	-10	-13	-18	-17	-23	-13	3	-6
EBITDA-CapEx	-3	-4	-2	-3	-2	-3	-7	-10	-13	-18	-17	-23	-13	3	-6
Operating Income (Loss)	-3	-4	-2	-3	-2	-3	-7	-10	-13	-18	-17	-23	-13	2	-6

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.97	0.31	0.52	1.31	2	9.77	17.19	13.92	6.01	12.93	12.76	5.16	1.76	3.85	3.5
Current Ratio	0.98	0.32	0.55	1.35	2.16	9.88	17.28	14.02	6.11	13.39	13.54	5.8	3.56	6.38	6.37
Quick Ratio	0.97	0.31	0.52	1.31	2	9.77	17.19	13.92	6.01	12.93	12.76	5.49	2.92	5.71	5.71
CFO/Avg Current Liab	-0.39	-0.47	-0.42	-0.68	-1.67	-4.87	-3.56	-4.77	-4.64	-6.75	-7.11	-5.77	-2.82	3.73	-1.43
Common Equity/Total Assets	-2.24	-209.6	-83.05	25.84	53.78	89.88	94.21	92.87	83.95	92.53	70.37	-9.54	-43.26	-13.06	50.28
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	31.63	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	24.03	111.5	160.02	143.58	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.25	92.43	115.14	43.02	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	31.63	-969.21	-266.32	-329.36	- -
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	24.03	111.5	160.12	143.6	- -
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.25	92.43	115.22	43.03	- -
CFO/Total Liabilities	-58.97	-40.89	-68.91	-96.59	-395.33	-528.36	-221.47	-478.07	-398.94	-664.47	-214.12	-61.2	-44.54	53.09	-35.56
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-29.72	-73	-91.49	-59.41	-134.4	1.94	61.67	38.14	17.81	41.54	-2.3	-7.16	-6.65	-2.56	1.24

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.99	4.1	4.38	2.47
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	183.69	88.96	83.3	147.6
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.3	0.92	1.98	2.87
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,222.33	396.02	184.33	127.27
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.42	0.92	0.59	1.08
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	873.08	396.5	613.49	336.7
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	532.94	88.48	-345.86	-61.82
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,038.64	-307.06	-101.03	20.33
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	1	2
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	1	2

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	28	19	29	184	127	129	194	114	253	303	174	263
- Cash & Cash Equivalents	5	2	2	2	1	4	28	23	14	30	21	24	13	27	37
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5	25	31	19	- -
Enterprise Value	-5	-2	-2	26	18	25	156	104	115	163	98	254	321	167	226
Total Capital	- -	-5	-1	1	1	4	27	21	12	29	21	22	19	13	35
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	24.03	111.5	160.12	143.6	- -
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.05	0.1	0.1	0.12	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	961.05	- -	165.6	15.1	3.51	5.07
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	50.83	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	67.24	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.21	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.21	- -
Diluted Market Cap	- -	- -	- -	27	19	27	150	121	130	177	114	252	298	172	220
Diluted Enterprise Value	-5	-2	-2	24	18	23	122	99	116	146	98	253	316	165	183
EV per Share	- -	- -	- -	2.47	1.66	1.85	8.49	5.23	5.8	6.28	3.78	9.64	11.87	6.06	6.62
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	21	48	45
TTM EBITDA	-3	-4	-2	-3	-2	-3	-7	-10	-13	-18	-17	-23	-13	3	-6
TTM Operating Income	-3	-4	-2	-3	-2	-3	-7	-10	-13	-18	-17	-23	-13	2	-6
TTM Cash Flow to Firm	-3	-3	-2	-2	-2	-2	-4	-8	-9	-16	-14	-17	-14	52	-10
TTM Free Cash Flow to Firm	-3	-3	-2	-2	-2	-2	-4	-8	-9	-16	-14	-17	-14	52	-10

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	-15.63	-10.14	-12.85	-41.32	-15.5	-14.3	-11.32	-8.05	-13.97	-17.39	6.39	-17.64
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	67.24	- -
Enterprise Value	-5	-2	-2	26	18	25	156	104	115	163	98	254	321	167	226
Low Price	- -	- -	- -	1.72	0.29	1.09	1.94	5.33	3.26	4.65	3.82	4.11	6.3	3.96	4.68
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	961.05	- -	165.6	15.1	3.51	5.07
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	50.83	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-11.38	-34.87	-9.11	-12.94	-18.08	-8.02	-9.37	-10.92	-7.37	-14.08	-455.55	-22.17
Price/Earnings High	- -	- -	- -	-15.2	-48.47	-14	-29.73	-28.83	-11.95	-13.97	-15.11	-11.5	-19.74	-719.28	-29.1
Price/Earnings Low	- -	- -	- -	-7.82	-4.72	-4.99	-4.14	-10.25	-5.09	-6.09	-5.73	-4.55	-10.43	-247.9	-13.73
Price/Book Value	- -	- -	- -	46.48	34.82	8.17	6.89	5.96	10.87	6.66	7.26	-98.51	-26.09	-29.63	7.42
Price/Book Value Average	- -	- -	- -	43.34	42.37	7.61	4.18	8.78	8.6	6.4	12.02	-68.23	-19.77	-34.11	7.28
Price/Book Value High	- -	- -	- -	57.89	58.89	11.69	9.6	13.99	12.82	9.54	16.63	-106.51	-27.72	-53.86	9.55
Price/Book Value Low	- -	- -	- -	29.77	5.73	4.17	1.34	4.98	5.46	4.16	6.3	-42.17	-14.65	-18.56	4.51
Price/Tangible Book Value	- -	- -	- -	46.48	34.82	8.17	6.89	5.96	10.87	6.66	7.26	-98.51	-26.09	-29.63	7.42
Price/Tangible Book Value Average	- -	- -	- -	43.34	42.37	7.61	4.18	8.78	8.6	6.4	12.02	-68.23	-19.77	-34.11	7.28
Price/Tangible Book Value High	- -	- -	- -	57.89	58.89	11.69	9.6	13.99	12.82	9.54	16.63	-106.51	-27.72	-53.86	9.55
Price/Tangible Book Value Low	- -	- -	- -	29.77	5.73	4.17	1.34	4.98	5.46	4.16	6.3	-42.17	-14.65	-18.56	4.51
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,038.79	- -	164.33	14.03	3.63	4.93
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	998.35	- -	113.82	10.63	4.18	4.84
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,487.77	- -	177.68	14.91	6.6	6.35
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	648.37	- -	70.35	7.88	2.27	3
Price/Cash Flow	- -	- -	- -	-15.63	-10.14	-12.85	-41.32	-15.5	-14.3	-11.32	-8.05	-13.97	-17.39	6.39	-17.64
Price/Cash Flow Average	- -	- -	- -	-14.57	-12.34	-11.96	-25.03	-22.84	-11.31	-10.88	-13.32	-9.67	-13.18	7.36	-17.31
Price/Cash Flow High	- -	- -	- -	-19.46	-17.15	-18.38	-57.52	-36.42	-16.85	-16.22	-18.43	-15.1	-18.48	11.62	-22.73
Price/Cash Flow Low	- -	- -	- -	-10.01	-1.67	-6.55	-8.01	-12.95	-7.18	-7.07	-6.99	-5.98	-9.77	4.01	-10.72
Price/Free Cash Flow Average	- -	- -	- -	-14.57	-12.34	-11.96	-25.03	-22.84	-11.31	-10.88	-13.32	-9.67	-13.18	7.36	-17.31
Price/Free Cash Flow High	- -	- -	- -	-19.46	-17.15	-18.38	-57.52	-36.42	-16.85	-16.22	-18.43	-15.1	-18.48	11.62	-22.73
Price/Free Cash Flow Low	- -	- -	- -	-10.01	-1.67	-6.55	-8.01	-12.95	-7.18	-7.07	-6.99	-5.98	-9.77	4.01	-10.72
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	916.69	- -	114.92	11.64	4.06	4.96
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,453.58	- -	178.99	15.99	6.5	6.77
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	532.76	- -	71.32	8.84	2.14	2.76
EV/EBITDA Average	1.54	0.64	0.86	-8.43	-11.79	-8.09	-12.01	-15.78	-6.8	-8.71	-10.07	-7.76	-18.95	58.87	-35.45
EV/EBITDA High	1.54	0.64	0.86	-11.53	-16.58	-13.17	-32.88	-26.46	-10.65	-13.82	-14.29	-12.08	-26.03	94.23	-48.39
EV/EBITDA Low	1.54	0.64	0.86	-5.54	-1.16	-3.81	-1.08	-8	-3.94	-5.06	-4.83	-4.81	-14.39	31.02	-19.72
EV/EBIT Average	1.54	0.64	0.86	-8.43	-11.79	-8.09	-12.01	-15.78	-6.8	-8.71	-10.07	-7.76	-18.95	77.86	-34.88
EV/EBIT High	1.54	0.64	0.86	-11.53	-16.58	-13.17	-32.88	-26.46	-10.65	-13.82	-14.29	-12.08	-26.03	124.64	-47.61
EV/EBIT Low	1.54	0.64	0.86	-5.54	-1.16	-3.81	-1.08	-8	-3.94	-5.06	-4.83	-4.81	-14.39	41.03	-19.4
Last Price	- -	- -	- -	2.69	1.74	2.14	10.02	6.38	6.49	7.45	4.4	9.6	11.22	6.32	7.7
High Price	- -	- -	- -	3.35	2.95	3.06	13.95	14.99	7.65	10.67	10.08	10.38	11.92	11.49	9.92
Enterprise Value Average	-5	-2	-2	24	22	23	84	164	89	156	173	176	247	193	221
Enterprise Value High	-5	-2	-2	33	31	38	229	275	139	247	246	275	340	309	302
Enterprise Value Low	-5	-2	-2	16	2	11	7	83	51	91	83	109	188	102	123

Shares Outstanding	8	8	10	11	11	14	18	20	20	26	26	26	27	28	34
Diluted Weighted Avg Shares	8	8	11	10	11	13	15	19	20	24	26	26	27	27	29
Basic Weighted Avg Shares	8	8	10	10	11	13	15	19	20	24	26	26	27	27	29
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.01	- -	0.06	0.8	1.74	1.56
EBITDA per Share	-0.43	-0.43	-0.2	-0.29	-0.17	-0.22	-0.46	-0.55	-0.65	-0.75	-0.66	-0.87	-0.49	0.12	-0.22
Operating Income per Share	-0.43	-0.43	-0.2	-0.29	-0.17	-0.22	-0.46	-0.55	-0.65	-0.75	-0.66	-0.87	-0.49	0.09	-0.22
Basic EPS, GAAP	0.59	-0.62	0.19	-0.22	-0.06	-0.22	-0.47	-0.52	-0.64	-0.76	-0.67	-0.9	-0.6	-0.02	-0.34
Basic EPS from Cont Ops	0.59	-0.62	0.19	-0.22	-0.06	-0.22	-0.47	-0.52	-0.64	-0.76	-0.67	-0.9	-0.6	-0.02	-0.34
Diluted EPS, GAAP	0.58	-0.62	0.17	-0.22	-0.06	-0.22	-0.47	-0.52	-0.64	-0.76	-0.67	-0.9	-0.6	-0.02	-0.34
Diluted EPS from Cont Ops	0.58	-0.62	0.17	-0.22	-0.06	-0.22	-0.47	-0.52	-0.64	-0.76	-0.67	-0.9	-0.6	-0.02	-0.34
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.4	-0.36	-0.23	-0.17	-0.17	-0.17	-0.24	-0.41	-0.45	-0.66	-0.55	-0.69	-0.65	0.99	-0.44
Free Cash Flow per Basic Share	-0.4	-0.36	-0.23	-0.17	-0.17	-0.17	-0.24	-0.41	-0.45	-0.66	-0.55	-0.69	-0.65	0.99	-0.44
Cash & Equivalents per Share	0.63	0.27	0.17	0.22	0.09	0.29	1.53	1.15	0.69	1.17	0.81	0.9	0.49	0.97	1.08
Book Value per Share	-0.01	-0.59	-0.15	0.06	0.05	0.26	1.45	1.07	0.6	1.12	0.61	-0.1	-0.43	-0.21	1.04
Tangible Book Value per Share	-0.01	-0.59	-0.15	0.06	0.05	0.26	1.45	1.07	0.6	1.12	0.61	-0.1	-0.43	-0.21	1.04

Fennec Pharmaceuticals Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)